Orbimed Advisors - CLEMENTIA PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of CLEMENTIA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$272,098,000
+121.9%
10,425,2250.0%4.21%
+85.8%
Q4 2018$122,601,000
+5.5%
10,425,2250.0%2.27%
+61.9%
Q3 2018$116,241,000
-15.3%
10,425,2250.0%1.40%
-14.4%
Q2 2018$137,196,000
-13.1%
10,425,2250.0%1.64%
-16.4%
Q1 2018$157,942,000
-20.2%
10,425,2250.0%1.96%
-21.8%
Q4 2017$197,871,000
+12.4%
10,425,2250.0%2.50%
+48.7%
Q3 2017$176,082,00010,425,2251.68%
Other shareholders
CLEMENTIA PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 10,425,225$176,082,0001.68%
NEA Management Company, LLC 2,141,697$36,173,0001.27%
RA Capital Management 585,403$9,887,0000.89%
DAFNA Capital Management LLC 60,000$1,013,0000.63%
DRIEHAUS CAPITAL MANAGEMENT LLC 819,508$13,841,0000.54%
EcoR1 Capital, LLC 194,166$3,279,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 163,000$2,753,0000.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 462,387$7,810,0000.35%
Rock Springs Capital Management LP 345,000$5,827,0000.27%
Perceptive Advisors 704,500$12,582,0000.24%
View complete list of CLEMENTIA PHARMACEUTICALS IN shareholders